Logo image of NORBT.OL

NORBIT ASA (NORBT.OL) Stock Fundamental Analysis

OSL:NORBT - Euronext Oslo - NO0010856511 - Common Stock - Currency: NOK

149.2  +4.8 (+3.32%)

Fundamental Rating

7

NORBT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 48 industry peers in the Electronic Equipment, Instruments & Components industry. NORBT gets an excellent profitability rating and is at the same time showing great financial health properties. NORBT is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, NORBT could be worth investigating further for growth and quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year NORBT was profitable.
NORBT had a positive operating cash flow in the past year.
Each year in the past 5 years NORBT has been profitable.
NORBT had a positive operating cash flow in each of the past 5 years.
NORBT.OL Yearly Net Income VS EBIT VS OCF VS FCFNORBT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

NORBT's Return On Assets of 11.13% is amongst the best of the industry. NORBT outperforms 95.83% of its industry peers.
NORBT has a better Return On Equity (21.02%) than 91.67% of its industry peers.
NORBT has a Return On Invested Capital of 15.32%. This is amongst the best in the industry. NORBT outperforms 95.83% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NORBT is significantly above the industry average of 6.99%.
Industry RankSector Rank
ROA 11.13%
ROE 21.02%
ROIC 15.32%
ROA(3y)10.75%
ROA(5y)8.24%
ROE(3y)20.73%
ROE(5y)15.61%
ROIC(3y)17.33%
ROIC(5y)13.48%
NORBT.OL Yearly ROA, ROE, ROICNORBT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

NORBT's Profit Margin of 13.89% is amongst the best of the industry. NORBT outperforms 97.92% of its industry peers.
NORBT's Profit Margin has improved in the last couple of years.
The Operating Margin of NORBT (19.70%) is better than 95.83% of its industry peers.
NORBT's Operating Margin has improved in the last couple of years.
NORBT's Gross Margin of 59.76% is fine compared to the rest of the industry. NORBT outperforms 77.08% of its industry peers.
NORBT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 19.7%
PM (TTM) 13.89%
GM 59.76%
OM growth 3Y29.01%
OM growth 5Y7.42%
PM growth 3Y31.71%
PM growth 5Y3.74%
GM growth 3Y3.52%
GM growth 5Y1.89%
NORBT.OL Yearly Profit, Operating, Gross MarginsNORBT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so NORBT is creating value.
The number of shares outstanding for NORBT has been increased compared to 1 year ago.
NORBT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NORBT is higher compared to a year ago.
NORBT.OL Yearly Shares OutstandingNORBT.OL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
NORBT.OL Yearly Total Debt VS Total AssetsNORBT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

NORBT has an Altman-Z score of 7.29. This indicates that NORBT is financially healthy and has little risk of bankruptcy at the moment.
NORBT's Altman-Z score of 7.29 is amongst the best of the industry. NORBT outperforms 91.67% of its industry peers.
The Debt to FCF ratio of NORBT is 1.89, which is an excellent value as it means it would take NORBT, only 1.89 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of NORBT (1.89) is better than 81.25% of its industry peers.
NORBT has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
NORBT has a Debt to Equity ratio (0.45) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 1.89
Altman-Z 7.29
ROIC/WACC1.81
WACC8.46%
NORBT.OL Yearly LT Debt VS Equity VS FCFNORBT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 2.03 indicates that NORBT has no problem at all paying its short term obligations.
NORBT has a better Current ratio (2.03) than 64.58% of its industry peers.
NORBT has a Quick Ratio of 1.12. This is a normal value and indicates that NORBT is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of NORBT (1.12) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 1.12
NORBT.OL Yearly Current Assets VS Current LiabilitesNORBT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.72% over the past year.
Measured over the past years, NORBT shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.16% on average per year.
Looking at the last year, NORBT shows a quite strong growth in Revenue. The Revenue has grown by 15.30% in the last year.
The Revenue has been growing by 21.25% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)25.72%
EPS 3Y67.64%
EPS 5Y22.16%
EPS Q2Q%133.8%
Revenue 1Y (TTM)15.3%
Revenue growth 3Y30.51%
Revenue growth 5Y21.25%
Sales Q2Q%40.43%

3.2 Future

NORBT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.79% yearly.
The Revenue is expected to grow by 15.68% on average over the next years. This is quite good.
EPS Next Y55.29%
EPS Next 2Y35.5%
EPS Next 3Y28.16%
EPS Next 5Y23.79%
Revenue Next Year32.82%
Revenue Next 2Y21.87%
Revenue Next 3Y31.03%
Revenue Next 5Y15.68%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
NORBT.OL Yearly Revenue VS EstimatesNORBT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
NORBT.OL Yearly EPS VS EstimatesNORBT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 38.16 indicates a quite expensive valuation of NORBT.
NORBT's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 24.29. NORBT is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 24.57 indicates a rather expensive valuation of NORBT.
NORBT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. NORBT is cheaper than 60.42% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.42, NORBT is valued a bit more expensive.
Industry RankSector Rank
PE 38.16
Fwd PE 24.57
NORBT.OL Price Earnings VS Forward Price EarningsNORBT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NORBT is on the same level as its industry peers.
NORBT's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 33.22
EV/EBITDA 19.99
NORBT.OL Per share dataNORBT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of NORBT may justify a higher PE ratio.
A more expensive valuation may be justified as NORBT's earnings are expected to grow with 28.16% in the coming years.
PEG (NY)0.69
PEG (5Y)1.72
EPS Next 2Y35.5%
EPS Next 3Y28.16%

4

5. Dividend

5.1 Amount

NORBT has a Yearly Dividend Yield of 2.12%.
Compared to an average industry Dividend Yield of 3.23, NORBT pays a bit more dividend than its industry peers.
NORBT's Dividend Yield is comparable with the S&P500 average which is at 2.43.
Industry RankSector Rank
Dividend Yield 2.12%

5.2 History

The dividend of NORBT has a limited annual growth rate of 5.27%.
Dividend Growth(5Y)5.27%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

NORBT pays out 62.84% of its income as dividend. This is not a sustainable payout ratio.
NORBT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP62.84%
EPS Next 2Y35.5%
EPS Next 3Y28.16%
NORBT.OL Yearly Income VS Free CF VS DividendNORBT.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 100M 200M
NORBT.OL Dividend Payout.NORBT.OL Dividend Payout, showing the Payout Ratio.NORBT.OL Dividend Payout.PayoutRetained Earnings

NORBIT ASA

OSL:NORBT (5/6/2025, 7:00:00 PM)

149.2

+4.8 (+3.32%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-13 2025-02-13/bmo
Earnings (Next)N/A N/A
Inst Owners18.24%
Inst Owner ChangeN/A
Ins Owners2.28%
Ins Owner ChangeN/A
Market Cap9.51B
Analysts84
Price Target153 (2.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.12%
Yearly Dividend2.47
Dividend Growth(5Y)5.27%
DP62.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-21.91%
Min EPS beat(2)-38.62%
Max EPS beat(2)-5.2%
EPS beat(4)1
Avg EPS beat(4)-7.08%
Min EPS beat(4)-38.62%
Max EPS beat(4)50.33%
EPS beat(8)4
Avg EPS beat(8)1.57%
EPS beat(12)6
Avg EPS beat(12)2.09%
EPS beat(16)7
Avg EPS beat(16)-2.59%
Revenue beat(2)0
Avg Revenue beat(2)-8.8%
Min Revenue beat(2)-15.14%
Max Revenue beat(2)-2.46%
Revenue beat(4)1
Avg Revenue beat(4)-4.41%
Min Revenue beat(4)-15.14%
Max Revenue beat(4)1.42%
Revenue beat(8)3
Avg Revenue beat(8)0%
Revenue beat(12)6
Avg Revenue beat(12)1.75%
Revenue beat(16)8
Avg Revenue beat(16)0.91%
PT rev (1m)11.11%
PT rev (3m)30.43%
EPS NQ rev (1m)-0.91%
EPS NQ rev (3m)41.56%
EPS NY rev (1m)0%
EPS NY rev (3m)8.66%
Revenue NQ rev (1m)-0.48%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)3.95%
Revenue NY rev (3m)5.1%
Valuation
Industry RankSector Rank
PE 38.16
Fwd PE 24.57
P/S 5.43
P/FCF 33.22
P/OCF 22.07
P/B 8.22
P/tB 39.47
EV/EBITDA 19.99
EPS(TTM)3.91
EY2.62%
EPS(NY)6.07
Fwd EY4.07%
FCF(TTM)4.49
FCFY3.01%
OCF(TTM)6.76
OCFY4.53%
SpS27.47
BVpS18.15
TBVpS3.78
PEG (NY)0.69
PEG (5Y)1.72
Profitability
Industry RankSector Rank
ROA 11.13%
ROE 21.02%
ROCE 20.19%
ROIC 15.32%
ROICexc 17.27%
ROICexgc 43.7%
OM 19.7%
PM (TTM) 13.89%
GM 59.76%
FCFM 16.35%
ROA(3y)10.75%
ROA(5y)8.24%
ROE(3y)20.73%
ROE(5y)15.61%
ROIC(3y)17.33%
ROIC(5y)13.48%
ROICexc(3y)18.7%
ROICexc(5y)14.35%
ROICexgc(3y)38.4%
ROICexgc(5y)28.67%
ROCE(3y)22.85%
ROCE(5y)17.76%
ROICexcg growth 3Y38.94%
ROICexcg growth 5Y14.4%
ROICexc growth 3Y27.69%
ROICexc growth 5Y2.09%
OM growth 3Y29.01%
OM growth 5Y7.42%
PM growth 3Y31.71%
PM growth 5Y3.74%
GM growth 3Y3.52%
GM growth 5Y1.89%
F-Score5
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 1.89
Debt/EBITDA 1.09
Cap/Depr 109.3%
Cap/Sales 8.26%
Interest Coverage 250
Cash Conversion 90.28%
Profit Quality 117.67%
Current Ratio 2.03
Quick Ratio 1.12
Altman-Z 7.29
F-Score5
WACC8.46%
ROIC/WACC1.81
Cap/Depr(3y)104.85%
Cap/Depr(5y)141.79%
Cap/Sales(3y)7.72%
Cap/Sales(5y)11.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.72%
EPS 3Y67.64%
EPS 5Y22.16%
EPS Q2Q%133.8%
EPS Next Y55.29%
EPS Next 2Y35.5%
EPS Next 3Y28.16%
EPS Next 5Y23.79%
Revenue 1Y (TTM)15.3%
Revenue growth 3Y30.51%
Revenue growth 5Y21.25%
Sales Q2Q%40.43%
Revenue Next Year32.82%
Revenue Next 2Y21.87%
Revenue Next 3Y31.03%
Revenue Next 5Y15.68%
EBIT growth 1Y21.44%
EBIT growth 3Y68.37%
EBIT growth 5Y30.25%
EBIT Next Year93.77%
EBIT Next 3Y34.13%
EBIT Next 5YN/A
FCF growth 1Y19.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y24.61%
OCF growth 3Y108.27%
OCF growth 5Y59.9%